Composite Lymphoma Comprising Follicular Lymphoma with In-situ Mantle Cell Neoplasia: A Case Report and Review of the Literature

  • Antonio Lapenna Unit of Anatomic Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
  • Antonella Bianchi Unit of Anatomic Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
  • Ombretta Annibali Unit of Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
  • Valeria Tomarchio Unit of Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
  • Silvia Maria Rossi Unit of Anatomic Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
  • Giuseppe Perrone Unit of Anatomic Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, Italy
Keywords: Haematopathology, Composite lymphoma, Follicular lymphoma, In situ mantle cell neoplasia

Abstract

A 55-year-old gentleman presented to our hospital with a single inguinal adenopathy, and no other clinical symptoms or signs. An excisional lymph node biopsy was performed. Pathologic evaluation demonstrated follicular center site which stained positive for CD20, CD10, Bcl-2, Bcl-6, and mantle zone cells which demonstrated Cyclin D1 (CCND1) positivity, partial SOX11 positivity and no expression of CD5, suggesting the diagnosis of composite lymphoma comprising follicular lymphoma (FL) with in situ mantle cell neoplasia (ISMCN), the latter previously referred as in situ mantle cell lymphoma (MCLIS). FL is known as indolent non-Hodgkin lymphoma; however, the clinical significance of a coexisting ISMCN continues to be elusive, and optimal management of these patients remains largely unknown. This paper reports a new case of this extremely uncommon condition and also discusses reviews of the literature including advances in molecular pathogenesis and lymphoma genomics with the aim to offer novel insights into this rare hematological malignancy.

References

Kim H. Composite lymphoma and related disorders. Am J Clin Pathol. 1993;99:445-451.

Wang E, Papavassiliou, Wang AR, et al. Composite lymphoid neoplasm of B-cell and T-cell origins: a pathologic study of 14 cases. Hum Pathol. 2014;45:768-784.

Wang S, Tzankov A, Xu-Monette ZY, et al. Clonally related composite follicular lymphoma and mantle cell lymphoma with clinicopathologic features and biological implications. Hum Pathol. 2013;44:2658-2667.

Taverna J, Nair A, Yun S, et al. A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literature. Case Rep Hematol. 2014;2014:145129.

Subtil A, Xu Z. Follicular lymphoma with composite in situ mantle cell neoplasia. Blood. 2019; 133(22):2460. https://doi.org/10.1182/blood.2019000012 10.1182/blood.2019000012

Hsi ED. 2016 WHO Classification update-What's new in lymphoid neoplasms. Int J Lab Hematol. 2017;Suppl1:14-22.

Carvajal-Cuenca A, Sua LF, Silva NM, et al., β€œIn situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.” Haematologica. 2012;97;2:270–278.

Adam P, Katzenberger T, Eifert M,et al. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol. 2005;29(12):1661-1664.

Cong P, Raffeld M, Teruya-Feldstein J, et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;1;99(9):3376-3382.

Jegalian AG, Eberle FC, Pack SD, et al. Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood. 2011;118(11):2976-2984.

Lecluse Y, Lebailly P, Roulland S,et al. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia. 2009;23(6):1190-1193.

Racke F, Simpson S, Christian B, et al. American Society of Hematology. Evidence of long latency periods prior to development of mantle cell lymphoma. [Abstract]; 2010; San Diego, CA. 2010

Espinet B, Sole F, Pedro C, et al. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol. 2005;36(11):1232-1237.

Miyazawa Y, Yokohama A, Ishizaki T, et al. Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein-Barr virus-positive follicular lymphoma. Int J Hematol. 2021;113(4):592-599.

P. Hsu, T. Yang, S. Sheikh-Fayyaz, et al. Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature. Int J Clin Exp Pathol. 2014;7;3: 1042–1050.

Published
2022-12-31
Section
Case Report